Over the years, May & Baker has continued to improve its year-end financial performance with a robust dividend policy. It is not surprising that it has become the toast of the investing public. That is why the public offer for subscription of our shares in the Nigeria Stock Exchange in 2006 was subscribed by 267 percent.
In 2004, May & Baker won the Gold Award of the Lagos State Ministry of Health in Occupational Health and Safety and in 2007 was awarded a prize of excellence in pharmaceutical manufacturing by the Federal Ministry of Health
In 2008, the company earned the much coveted NIS ISO 9001: 2000 certificate for its quality management system and its Food Division was also granted the Mandatory Conformity Assessment Certificate Programme (MANCAP) for its Mimee Noodles brands by the Standards Organization of Nigeria (SON).
In the first quarter of 2010, May & Baker will commission the first World Health Organisation (WHO) standard pharmaceutical plant in Nigeria, and one of the largest plants in Africa. The plant is scheduled to receive WHO Pre-Qualification Certificate within a year of its opening.